title: [C-MOPP therapy in advanced diffuse lymphoma, large cell type (LSG)].
authors: T
authors: T
authors: Ino
authors: M
authors: M
authors: Okamoto
authors: K
authors: K
authors: Shinkai
authors: H
authors: H
authors: Kojima
authors: F
authors: F
authors: Maruyama
authors: R
authors: R
authors: Sobue
authors: N
authors: N
authors: Ito
authors: H
authors: H
authors: Imura
authors: T
authors: T
authors: Takada
authors: K
authors: K
authors: Morikawa
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone